Eric M. Krauland active positions
| Companies | Position | Start | End |
|---|---|---|---|
Adimab LLC
 Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Chief Tech/Sci/R&D Officer | 31/05/2017 | - |
| President | 08/05/2022 | - | |
| Corporate Officer/Principal | - | 08/05/2022 |
Career history of Eric M. Krauland
Training of Eric M. Krauland
| The Johns Hopkins University | Undergraduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
Statistics
International
| United States | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| President | 1 |
Sectoral
| Health Technology | 2 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
- Stock Market
- Insiders
- Eric M. Krauland
- Experience
